Madredondo, Fredilyn L.

HRN: 22-21-45  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/14/2022
CEFUROXIME 1.5GM (VIAL)
12/14/2022
12/14/2022
IVTT
Now
Now
For CS
Waiting Final Action 
12/15/2022
CEFUROXIME 1.5GM (VIAL)
12/15/2022
12/17/2022
IVTT
1.5gm
Q 8hrs
SP CS
Waiting Final Action 
12/15/2022
CEFUROXIME 500MG (TAB)
12/15/2022
12/21/2022
ORAL
500mg
BID
S/p Primary LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: